Angiopoietin-like 3 Is a Potential Biomarker for Retinopathy in Type 2 Diabetic Patients.
Sign Up to like & getrecommendations! Published in 2018 at "American journal of ophthalmology"
DOI: 10.1016/j.ajo.2018.03.040
Abstract: PURPOSE To investigate whether angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) are differentially associated with the severity of retinopathy in patients with type 2 diabetes mellitus (T2DM). DESIGN Cross-sectional study. METHODS Serum levels of ANGPTL3,… read more here.
Keywords: retinopathy; vegf; angptl3 angptl4; biomarker ... See more keywords
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: new therapeutic approaches for the treatment of atherogenic dyslipidemia.
Sign Up to like & getrecommendations! Published in 2020 at "Pharmacological research"
DOI: 10.1016/j.phrs.2020.104653
Abstract: Among the determinants of atherosclerotic cardiovascular disease (ASCVD), genetic and experimental evidence has provided data on a major role of angiopoietin-like proteins 3 and 4 (ANGPTL3 and ANGPTL4) in regulating the activity of lipoprotein lipase… read more here.
Keywords: rich lipoproteins; angptl3 angptl4; treatment; density lipoprotein ... See more keywords
Circulating ANGPTL3 and ANGPTL4 levels predict coronary artery atherosclerosis severity
Sign Up to like & getrecommendations! Published in 2021 at "Lipids in Health and Disease"
DOI: 10.1186/s12944-021-01580-z
Abstract: Background We investigated the role of ANGPTL3 and ANGPTL4 in atherosclerosis development and determined whether plasma concentrations of ANGPTL3 and ANGPTL4 are related to the degree of coronary stenosis. Methods A total of 305 consecutive… read more here.
Keywords: angptl3 angptl4; angptl4 levels; atherosclerosis; coronary artery ... See more keywords